Does N ratio affect survival in D1 and D2 lymph node dissection for gastric cancer?

被引:11
|
作者
Sakcak, Ibrahim [1 ]
Yildiz, Baris Dogu [1 ]
Avsar, Fatih Mehmet [1 ]
Akturan, Saadet [3 ]
Kilic, Kemal [2 ]
Cosgun, Erdal [4 ]
Hamamci, Enver O. [1 ]
机构
[1] Numune Teaching & Res Hosp, Dept Gen Surg 6, TR-06100 Ankara, Turkey
[2] Kafkas Univ, Fac Med, Dept Gen Surg, TR-36000 Kars, Turkey
[3] Etlik Teaching & Res Hosp, DeDepartment Gen Surg, TR-06010 Ankara, Turkey
[4] Hacettepe Univ, Fac Med, Dept Stat, TR-06100 Ankara, Turkey
关键词
Gastric cancer; Lymph node dissection; Node ratio; Tumor nodule metastasis; INDEPENDENT PROGNOSTIC-FACTOR; STAGE MIGRATION; RANDOMIZED TRIAL; GASTRECTOMY; RESECTION; NUMBER; LYMPHADENECTOMY; CLASSIFICATION; METASTASIS; MORBIDITY;
D O I
10.3748/wjg.v17.i35.4007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To identify whether there could have been changes in survival if lymph node ratio (N ratio) had been used. METHODS: We assessed 334 gastric adenocarcinoma cases retrospectively between 2001 and 2009. Two hundred and sixteen patients out of 334 were included in the study. Patients were grouped according to disection1 (D1) or dissection 2 (D2) dissection. We compared the estimated survival and actual survival determined by pathologic nodes (pN) class and N ratio, and SPSS 15.0 software was used for statistical analysis. RESULTS: Ninety-six (44.4%) patients underwent D1 dissection and 120 (55.6%) had D2 dissection. When groups were evaluated, 23 (24.0%) patients in D1 and 21 (17.5%) in D2 had stage migration (P = 0.001). When both D1 and D2 groups were evaluated for number of pathological lymph nodes, despite the fact that there was no difference in N ratio between D1 and D2 groups, a statistically significant difference was found between them with regard to pN1 and pN2 groups (P = 0.047, P = 0.044 respectively). In D1, pN0 had the longest survival while pN3 had the shortest. In D2, pN0 had the longest survival whereas pN3 had the shortest survival. CONCLUSION: N ratio is an accurate staging system for defining prognosis and treatment plan, thus decreasing methodological errors in gastric cancer staging. (c) 2011 Baishideng. All rights reserved.
引用
收藏
页码:4007 / 4012
页数:6
相关论文
共 50 条
  • [21] Result of laparoscopy gastrectomy with D2 lymph node dissection for advanced gastric cancer
    Cuong, Cuong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 512 - 512
  • [22] D2 vs D2 plus para-aortic lymph node dissection for advanced gastric cancer
    Ozmen, Mehmet Mahir
    Zulfikaroglu, Baris
    Ozmen, Fusun
    Moran, Munevver
    Ozalp, Necdet
    Seckin, Selda
    TURKISH JOURNAL OF SURGERY, 2021, 37 (01) : 49 - 58
  • [23] Gallstone Disease after Extended (D2) Lymph Node Dissection for Gastric Cancer
    Tomotaka Akatsu
    Masashi Yoshida
    Tetsuro Kubota
    Motohide Shimazu
    Masakazu Ueda
    Yoshihide Otani
    Go Wakabayashi
    Koichi Aiura
    Minoru Tanabe
    Toshiharu Furukawa
    Yoshiro Saikawa
    Shigeyuki Kawachi
    Yukako Akatsu
    Koichiro Kumai Masaki Kitajima
    World Journal of Surgery, 2005, 29 : 182 - 186
  • [24] Extended (D2) lymph node dissection for gastric cancer: Do patients benefit?
    Roukos, DH
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (04) : 253 - 255
  • [25] Extended (D2) Lymph Node Dissection for Gastric Cancer: Do Patients Benefit?
    Dimitrios H. Roukos
    Annals of Surgical Oncology, 2000, 7 : 253 - 255
  • [26] Gallstone disease after extended (D2) lymph node dissection for gastric cancer
    Akatsu, T
    Yoshida, M
    Kubota, T
    Shimazu, M
    Ueda, M
    Otani, Y
    Wakabayashi, G
    Aiura, K
    Tanabe, M
    Furukawa, T
    Saikawa, Y
    Kawachi, S
    Akatsu, Y
    Kumai, K
    Kitajima, M
    WORLD JOURNAL OF SURGERY, 2005, 29 (02) : 182 - 186
  • [27] Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer
    Wang, Xin
    Wang, Wei-Hu
    Wang, Shu-Lian
    Song, Yong-Wen
    Liu, Yue-Ping
    Tang, Yuan
    Li, Ning
    Liu, Wen-Yang
    Fang, Hui
    Li, Ye-Xiong
    Zhao, Dong-Bing
    Chi, Yihebali
    Yang, Lin
    Jin, Jing
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2021, 13 (10) : 1532 - 1543
  • [28] Efficacy and toxicity of capecitabine combined with intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with gastric cancer
    Xin Wang
    Wei-Hu Wang
    Shu-Lian Wang
    Yong-Wen Song
    Yue-Ping Liu
    Yuan Tang
    Ning Li
    Wen-Yang Liu
    Hui Fang
    Ye-Xiong Li
    Dong-Bing Zhao
    Yihebali Chi
    Lin Yang
    Jing Jin
    World Journal of Gastrointestinal Oncology, 2021, 13 (10) : 1532 - 1543
  • [29] Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
    Lee, S.
    Kim, I-H.
    Shin, K.
    ANNALS OF ONCOLOGY, 2019, 30
  • [30] Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage
    Kabsoo Shin
    Se Jun Park
    Jinsoo Lee
    Cho Hyun Park
    Kyo Young Song
    Han Hong Lee
    Ho Seok Seo
    Yoon Ju Jung
    Jae Myung Park
    Sung Hak Lee
    Sang Young Roh
    In-Ho Kim
    BMC Cancer, 19